Fulton Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,532
Closed -$241K 434
2019
Q4
$241K Sell
2,532
-144
-5% -$12.5K 0.02% 390
2019
Q3
$204K Sell
2,676
-215
-7% -$17.9K 0.01% 409
2019
Q2
$254K Sell
2,891
-10,064
-78% -$858K 0.02% 359
2019
Q1
$1.17M Hold
12,955
0.08% 174
2018
Q4
$930K Hold
12,955
0.07% 184
2018
Q3
$1.24M Hold
12,955
0.08% 179
2018
Q2
$1.23M Buy
12,955
+75
+0.6% +$6.89K 0.09% 171
2018
Q1
$1.13M Hold
12,880
0.08% 173
2017
Q4
$1.09M Sell
12,880
-1,100
-8% -$92.2K 0.08% 173
2017
Q3
$1.21M Buy
13,980
+287
+2% +$23K 0.09% 160
2017
Q2
$1.06M Hold
13,693
0.08% 162
2017
Q1
$949K Sell
13,693
-979
-7% -$65.7K 0.08% 169
2016
Q4
$868K Sell
14,672
-191
-1% -$11.8K 0.08% 172
2016
Q3
$985K Sell
14,863
-21,447
-59% -$1.33M 0.09% 158
2016
Q2
$1.96M Sell
36,310
-8,595
-19% -$471K 0.19% 110
2016
Q1
$2.32M Buy
44,905
+7,917
+21% +$411K 0.24% 94
2015
Q4
$2.6M Buy
36,988
+20,945
+131% +$1.43M 0.27% 81
2015
Q3
$999K Buy
16,043
+1,931
+14% +$152K 0.11% 142
2015
Q2
$1.19M Buy
14,112
+1,104
+8% +$85.9K 0.12% 138
2015
Q1
$978K Buy
+13,008
New +$909K 0.1% 157

Other funds holding XBI

Fulton Bank's XBI Position: Q1 2020 in Review

Fulton Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 2,532 shares — an estimated $241K sold.

Fulton Bank first reported a position in XBI in Q1 2015 and held it in 20 quarters. The position peaked at $2.6M in Q4 2015. 459 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

  • Fulton Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
  • Fulton Bank sold 2,532 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $241K.
  • Fulton Bank first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 20 quarters.
  • Fulton Bank's State Street SPDR S&P Biotech ETF position peaked at $2.6M in Q4 2015.
  • 459 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on Fulton Bank's 13F filing for Q1 2020, filed 3 Apr 2020.